InsidersTradesSigma
Follow the Australian Clinical Labs Limited share price and the full management transaction log of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, Australian Clinical Labs Limited has recorded 15 reports. Market capitalisation: €557.7m. The latest transaction was reported on 24 August 2026 (Cease Substantial Holding). Among the most active insiders: There was a change in the interests of the. All data is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Australian Clinical Labs Limited Buy (bullish), based on 8 analysts. Average price target: A$2.88.
Fundamental score
Ranked 1,650 of 29,062 companies
78.1
score / 100
Value88
Quality69
FCF yld33%
Earn yld6.2%
EV/EBITDA4.3x
ROE15%
Gross mgn83%
Net mgn4.4%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 August 2026
Declarations15 total
ShareASXISIN AU0000148496ASX:2924-03124420-3A699463
ShareASXISIN AU0000148496ASX:2924-03123811-3A699350
ShareASXISIN AU0000148496ASX:2924-03112073-3A697333
ShareASXISIN AU0000148496ASX:2924-03111737-3A697278
●
ShareASXISIN AU0000148496ASX:2924-03092202-3A693702
ShareASXISIN AU0000148496ASX:2924-03092061-3A693677
ShareASXISIN AU0000148496ASX:2924-03086307-3A692634
ShareASXISIN AU0000148496ASX:2924-03082737-3A692020
15 of 15 declarations
关于 Australian Clinical Labs Limited
Australian Clinical Labs Limited 是一家澳大利亚公司，专门从事临床实验室服务。它在全国范围内提供诊断检测和医学分析。